The tumble of once highflying tech stocks signals a potential shift in investors chasing eye-popping growth, the New York Times reports.» Read More
Investors can benefit from certain health care companies that will be boosted by the stimulus package, said Les Funtleyder, health care strategist of Miller Tabak.
It's still not clear what, if any, reform is going to come to health care in America, but Miller Tabak's Les Funtleyder is ready to play it. "There are some companies we like in the genetics space, which would benefit by increased NIH [National Institutes of Health] spending."
The Lightning Round is extended in this CNBC.com exclusive feature.
Following are the day's biggest winners and losers. Find out why shares of Illumina popped while Posco dropped and more.
Analyst actions and corporate announcements were some of the catalysts behind the most actively traded stocks on Thursday.